ONY

CRTX respiratory distress drug study draws $10M lawsuit from ONY

Cornerstone Therapeutics (NASDAQ:CRTX) is in the crosshairs of competitor ONY over a published study that concludes its respiratory drug is riskier to infants than Cornerstone’s. Privately held ONY claims damages of $10 million and is now seeking to recover them through a lawsuit that targets Cornerstone; Italian company Chiesi Farmaceutici, which licensed the drug to […]

By Frank Vinluan

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab